Torthaí cuardaigh - Spring, Laura
- 1 - 20 toradh as 29 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Targeting the cyclin D–cyclin-dependent kinase (CDK)4/6–retinoblastoma pathway with selective CDK 4/6 inhibitors in hormone receptor-positive breast cancer: rationale, current stat... de réir Spring, Laura, Bardia, Aditya, Modi, Shanu
Foilsithe / Cruthaithe 2016Téacs -
2
-
3
Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations de réir Spring, Laura M., Zangardi, Mark L., Moy, Beverly, Bardia, Aditya
Foilsithe / Cruthaithe 2017Téacs -
4
CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions de réir Spring, Laura M., Wander, Seth A., Zangardi, Mark, Bardia, Aditya
Foilsithe / Cruthaithe 2019Téacs -
5
-
6
Stevens-Johnson syndrome–like eruption from palbociclib in a patient with metastatic breast cancer de réir Karagounis, Theodora, Vallurupalli, Mounica, Nathan, Neera, Nazarian, Rosalynn, Vedak, Priyanka, Spring, Laura, Chen, Steven T.
Foilsithe / Cruthaithe 2018Téacs -
7
Sacituzumab Govitecan for Metastatic Triple‐Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities de réir Spring, Laura M., Nakajima, Erika, Hutchinson, Jennifer, Viscosi, Elene, Blouin, Gayle, Weekes, Colin, Rugo, Hope, Moy, Beverly, Bardia, Aditya
Foilsithe / Cruthaithe 2021Téacs -
8
Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis de réir Spring, Laura M., Gupta, Arjun, Reynolds, Kerry L., Gadd, Michele A., Ellisen, Leif W., Isakoff, Steven J., Moy, Beverly, Bardia, Aditya
Foilsithe / Cruthaithe 2016Téacs -
9
Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series de réir Gazourian, Lee, Spring, Laura, Meserve, Emily, Hwang, David, Diaz, Alejandro A., Ash, Samuel Y., Ho, Vincent T., Sholl, Lynette M., Washko, George R.
Foilsithe / Cruthaithe 2017Téacs -
10
Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic de réir Spring, Laura M., Specht, Michelle C., Jimenez, Rachel B., Isakoff, Steven J., Wang, Gary X., Ly, Amy, Shin, Jennifer A., Bardia, Aditya, Moy, Beverly
Foilsithe / Cruthaithe 2020Téacs -
11
A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entry de réir Smith, Barbara L., Nguyen, Anvy, Korotkin, Jenna E., Kelly, Bridget N., Specht, Michelle C., Spring, Laura M., Moy, Beverly, Isakoff, Steven J., Gadd, Michele A.
Foilsithe / Cruthaithe 2020Téacs -
12
Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer de réir Bychkovsky, Brittany L., Guo, Hao, Sutton, Jazmine, Spring, Laura, Faig, Jennifer, Dagogo-Jack, Ibiayi, Battelli, Chiara, Houlihan, Mary Jane, Yeh, Tsai-Chu, Come, Steven E., Lin, Nancy U.
Foilsithe / Cruthaithe 2016Téacs -
13
Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis de réir Spring, Laura M., Fell, Geoffrey, Arfe, Andrea, Sharma, Chandni, Greenup, Rachel, Reynolds, Kerry L., Smith, Barbara L., Alexander, Brian, Moy, Beverly, Isakoff, Steven J., Parmigiani, Giovanni, Trippa, Lorenzo, Bardia, Aditya
Foilsithe / Cruthaithe 2020Téacs -
14
Locally Recurrent Secretory Carcinoma of the Breast with NTRK3 Gene Fusion de réir Mortensen, Lindsey, Ordulu, Zehra, Dagogo‐Jack, Ibiayi, Bossuyt, Veerle, Winters, Loren, Taghian, Alphonse, Smith, Barbara L., Ellisen, Leif W., Kiedrowski, Lesli A., Lennerz, Jochen K., Bardia, Aditya, Spring, Laura M.
Foilsithe / Cruthaithe 2021Téacs -
15
Phase 1b clinical trial of ado-trastuzumab emtansine and ribociclib for HER2-positive metastatic breast cancer de réir Spring, Laura M., Clark, Shealagh L., Li, Tianyu, Goel, Shom, Tayob, Nabihah, Viscosi, Elene, Abraham, Elizabeth, Juric, Dejan, Isakoff, Steven J., Mayer, Erica, Moy, Beverly, Supko, Jeffrey G., Tolaney, Sara M., Bardia, Aditya
Foilsithe / Cruthaithe 2021Téacs -
16
Effectiveness and tolerability of neoadjuvant pertuzumab containing regimens for HER2-positive localized breast cancer. de réir Spring, Laura, Niemierko, Andrzej, Haddad, Stephanie, Yuen, Megan, Comander, Amy, Reynolds, Kerry, Shin, Jennifer, Bahn, Atul, Brachtel, Elena, Specht, Michelle, Smith, Barbara L., Taghian, Alphonse, Jimenez, Rachel, Peppercorn, Jeffrey, Isakoff, Steven J., Moy, Beverly, Bardia, Aditya
Foilsithe / Cruthaithe 2018Téacs -
17
FGFR1 gene amplification mediates endocrine resistance but retains TORC sensitivity in metastatic hormone receptor positive (HR+) breast cancer de réir Drago, Josh, Formisano, Luigi, Juric, Dejan, Niemierko, Andrzej, Servetto, Alberto, Wander, Seth, Spring, Laura, Vidula, Neelima, Peppercorn, Jeffrey, Younger, Jerry, Malvarosa, Giuliana, Yuen, Megan, Sgroi, Dennis, Isakoff, Steven J., Moy, Beverly, Ellisen, Leif W., Iafrate, John, Arteaga, Carlos L., Bardia, Aditya
Foilsithe / Cruthaithe 2019Téacs -
18
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses de réir Koh, Siang-Boon, Dontchos, Brian N., Bossuyt, Veerle, Edmonds, Christine, Cristea, Simona, Melkonjan, Nsan, Mortensen, Lindsey, Ma, Annie, Beyerlin, Kassidy, Denault, Elyssa, Niehoff, Elizabeth, Hirz, Taghreed, Sykes, David B., Michor, Franziska, Specht, Michelle, Lehman, Constance, Ellisen, Leif W., Spring, Laura M.
Foilsithe / Cruthaithe 2021Téacs -
19
A digital RNA signature of Circulating Tumor Cells predicting early therapeutic response in localized and metastatic breast cancer de réir Kwan, Tanya T., Bardia, Aditya, Spring, Laura M., Giobbie-Hurder, Anita, Kalinich, Mark, Dubash, Taronish, Sundaresan, Tilak, Hong, Xin, LiCausi, Joseph A., Ho, Uyen, Silva, Erin J., Wittner, Ben S., Sequist, Lecia V., Kapur, Ravi, Miyamoto, David T., Toner, Mehmet, Haber, Daniel A., Maheswaran, Shyamala
Foilsithe / Cruthaithe 2018Téacs -
20
Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy de réir Griffiths, Jason I., Chen, Jinfeng, Cosgrove, Patrick A., O’Dea, Anne, Sharma, Priyanka, Ma, Cynthia, Trivedi, Meghna, Kalinsky, Kevin, Wisinski, Kari B., O’Regan, Ruth, Makhoul, Issam, Spring, Laura M., Bardia, Aditya, Adler, Frederick R., Cohen, Adam L., Chang, Jeffrey T., Khan, Qamar J., Bild, Andrea H.
Foilsithe / Cruthaithe 2021Téacs